Abaxis, Inc. (ABAX) Touches $83.53 High on May, 18; Profile of 5 Analysts Covering NN, Inc. (NNBR)

May 18, 2018 - By Sheldon Barnett

Abaxis, Inc. (NASDAQ:ABAX) Logo

Among 8 analysts covering NN Inc (NASDAQ:NNBR), 5 have Buy rating, 1 Sell and 2 Hold. Therefore 63% are positive. NN Inc had 12 analyst reports since July 24, 2015 according to SRatingsIntel. As per Friday, March 11, the company rating was maintained by Avondale. As per Wednesday, December 21, the company rating was initiated by Lake Street. The stock has “Hold” rating by Stifel Nicolaus on Thursday, August 3. The company was initiated on Friday, July 24 by Stephens. The firm has “Buy” rating given on Tuesday, August 18 by Stifel Nicolaus. Stifel Nicolaus downgraded the shares of NNBR in report on Monday, October 26 to “Hold” rating. On Friday, August 28 the stock rating was upgraded by Zacks to “Sell”. William Blair initiated the shares of NNBR in report on Thursday, September 3 with “Mkt Perform” rating. On Friday, September 15 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. The stock has “Hold” rating by Stifel Nicolaus on Monday, March 12. See NN, Inc. (NASDAQ:NNBR) latest ratings:

12/03/2018 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Hold Old Target: $29 New Target: $28 Maintain

The stock of Abaxis, Inc. (NASDAQ:ABAX) reached all time high today, May, 18 and still has $86.04 target or 3.00% above today’s $83.53 share price. This indicates more upside for the $1.90B company. This technical setup was reported by Barchart.com. If the $86.04 PT is reached, the company will be worth $56.88 million more. The stock decreased 0.23% or $0.19 during the last trading session, reaching $83.53. About 155,522 shares traded. Abaxis, Inc. (NASDAQ:ABAX) has risen 44.47% since May 18, 2017 and is uptrending. It has outperformed by 32.92% the S&P500.

Investors sentiment increased to 1.23 in Q4 2017. Its up 0.27, from 0.96 in 2017Q3. It increased, as 11 investors sold NN, Inc. shares while 29 reduced holdings. 17 funds opened positions while 32 raised stakes. 24.56 million shares or 0.67% more from 24.40 million shares in 2017Q3 were reported. Alliancebernstein Lp holds 0% of its portfolio in NN, Inc. (NASDAQ:NNBR) for 31,300 shares. State Street has invested 0% in NN, Inc. (NASDAQ:NNBR). Moreover, Ubs Asset Management Americas has 0% invested in NN, Inc. (NASDAQ:NNBR). Credit Suisse Ag holds 0% or 31,261 shares in its portfolio. Primecap Management Co Ca has 0.04% invested in NN, Inc. (NASDAQ:NNBR) for 1.98M shares. Virginia Retirement Et Al holds 0.01% or 15,700 shares. Cap Fund Mngmt Sa holds 0% or 7,800 shares in its portfolio. Skyline Asset Mgmt Lp stated it has 817,200 shares or 1.81% of all its holdings. Moreover, Nuveen Asset Mgmt Limited Liability Corp has 0.21% invested in NN, Inc. (NASDAQ:NNBR). Raymond James And Assoc owns 126,801 shares for 0.01% of their portfolio. Daruma Management Limited Liability Corporation stated it has 1.55 million shares. Gsa Capital Partners Llp invested in 0.03% or 16,043 shares. Aqr Capital Management Limited Liability Company accumulated 10,764 shares or 0% of the stock. Voya Inv Management Ltd stated it has 0% in NN, Inc. (NASDAQ:NNBR). Moreover, D E Shaw & has 0.01% invested in NN, Inc. (NASDAQ:NNBR) for 201,059 shares.

NN, Inc., a diversified industrial company, makes high precision bearing components, industrial plastic products, and precision metal components to various markets in North America, Western Europe, Eastern Europe, South America, and China. The company has market cap of $629.41 million. The firm operates through three divisions: Precision Bearing Components Group, Precision Engineered Products Group, and Autocam Precision Components Group. It has a 3.87 P/E ratio. The Precision Bearing Components Group segment makes and sells precision steel balls that are used primarily by manufacturers of anti-friction bearings and constant velocity joints; steel rollers, including tapered rollers used in automotive gearbox applications, automotive wheel bearings, and various industrial applications; cylindrical rollers used in various industrial applications; and precision metal retainers for roller bearings.

More news for NN, Inc. (NASDAQ:NNBR) were recently published by: Seekingalpha.com, which released: “NN’s (NNBR) CEO Richard Holder on Q1 2018 Results – Earnings Call Transcript” on May 12, 2018. Nasdaq.com‘s article titled: “Consolidated Research: 2018 Summary Expectations for RPX, Cotiviti, NN, Dynex Capital, ChromaDex, and Cogent …” and published on April 25, 2018 is yet another important article.

The stock increased 0.22% or $0.05 during the last trading session, reaching $22.75. About 43,276 shares traded. NN, Inc. (NASDAQ:NNBR) has declined 2.97% since May 18, 2017 and is downtrending. It has underperformed by 14.52% the S&P500.

Investors sentiment decreased to 1.27 in 2017 Q4. Its down 0.05, from 1.32 in 2017Q3. It is negative, as 12 investors sold Abaxis, Inc. shares while 40 reduced holdings. 25 funds opened positions while 41 raised stakes. 21.66 million shares or 0.81% less from 21.83 million shares in 2017Q3 were reported. Rhumbline Advisers, a Massachusetts-based fund reported 72,639 shares. Jpmorgan Chase And has 0% invested in Abaxis, Inc. (NASDAQ:ABAX) for 93,999 shares. 26 were accumulated by Tci Wealth Advisors. Primecap Mngmt Com Ca invested in 0.08% or 2.22 million shares. Ameriprise has invested 0% in Abaxis, Inc. (NASDAQ:ABAX). Hutchin Hill L P invested 0.1% of its portfolio in Abaxis, Inc. (NASDAQ:ABAX). Royal Bancorp Of Canada holds 473,511 shares or 0.01% of its portfolio. Stratos Wealth Prns Limited holds 0% or 110 shares in its portfolio. Laurion L P holds 9,091 shares or 0% of its portfolio. Us Bank De reported 0.01% stake. Wesbanco Savings Bank Incorporated invested in 0.02% or 5,500 shares. Credit Suisse Ag owns 24,194 shares. State Teachers Retirement Systems has 48,074 shares for 0.01% of their portfolio. Metropolitan Life Ins Commerce New York has 7,377 shares. Fifth Third Commercial Bank holds 0% or 191 shares in its portfolio.

More notable recent Abaxis, Inc. (NASDAQ:ABAX) news were published by: 247Wallst.com which released: “Are Abaxis Shareholders Getting Enough in the Buyout?” on May 16, 2018, also Benzinga.com with their article: “Benzinga’s Daily Biotech Pulse: AstraZeneca’s Q1, Novartis-Amgen Migraine Drug Approved” published on May 18, 2018, Nasdaq.com published: “Mid-Afternoon Market Update: Blink Charging Rises After Q1 Results; Purple Innovation Shares Slide” on May 16, 2018. More interesting news about Abaxis, Inc. (NASDAQ:ABAX) were released by: Prnewswire.com and their article: “WeissLaw LLP Investigates Abaxis Inc.” published on May 17, 2018 as well as Businesswire.com‘s news article titled: “Bragar Eagel & Squire, PC is Investigating the Board of Directors of Abaxis, Inc. (ABAX) on Behalf of Stockholders and …” with publication date: May 16, 2018.

Analysts await Abaxis, Inc. (NASDAQ:ABAX) to report earnings on July, 26. They expect $0.35 EPS, up 25.00% or $0.07 from last year’s $0.28 per share. ABAX’s profit will be $7.94M for 59.66 P/E if the $0.35 EPS becomes a reality. After $0.42 actual EPS reported by Abaxis, Inc. for the previous quarter, Wall Street now forecasts -16.67% negative EPS growth.

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide. The company has market cap of $1.90 billion. It operates in two divisions, Medical Market and Veterinary Market. It has a 77.34 P/E ratio. The firm offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents.

NN, Inc. (NASDAQ:NNBR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: